157 results on '"Williams, Marlene S."'
Search Results
2. Indoor particulate matter concentrations and air cleaner intervention association with biomarkers in former smokers with COPD
3. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
4. 2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Data Standards
5. Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial
6. 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions): A Report of the ACC Competency Management Committee
7. Center Variation in Use of Preoperative Dual Antiplatelet Therapy and Platelet Function Testing at the Time of Coronary Artery Bypass Grafting in Maryland
8. Indoor particulate matter concentrations and air cleaner intervention association with biomarkers in former smokers with COPD
9. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
10. Abstract 15287: Evolocumab Inhibits the Acute Rise in Lipoprotein(a) in Patients With Non-ST Elevation Myocardial Infarction (NSTEMI)- Results From the EVACS Study
11. Effect of Evolocumab on Atherogenic Lipoproteins During the Peri- and Early Postinfarction Period: A Placebo-Controlled, Randomized Trial
12. Alternative cardiac intensive care unit locations during the COVID-19 pandemic at an academic medical center
13. Gender differences in platelet brain derived neurotrophic factor in patients with cardiovascular disease and depression
14. Platelet Serotonin Signaling in Patients With Cardiovascular Disease and Comorbid Depression
15. Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition
16. 2022 ACC/AHA Key Data Elements and Definitions for Chest Pain and Acute Myocardial Infarction: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Data Standards
17. Platelet Response to Serotonin in Patients With Stable Coronary Heart Disease
18. Do Platelet-Derived Microparticles Play a Role in Depression, Inflammation, and Acute Coronary Syndrome?
19. Large Atrial Septal Aneurysm Associated with Secundum Atrial Septal Defect
20. The Trajectory of Lipoprotein(a) During the Peri- and Early Postinfarction Period and the Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition
21. sj-pdf-2-vmj-10.1177_1358863X20987551 – Supplemental material for 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions)
22. sj-pdf-1-vmj-10.1177_1358863X20987551 – Supplemental material for 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions)
23. Urine and Plasma Markers of Platelet Activation and Respiratory Symptoms in COPD
24. Abstract 12563: The Trajectory of Platelet Factor 4 in Acute Myocardial Infarction and the Impact of PCSK9-Inhibition
25. Racial differences in platelet serotonin polymorphisms in acute coronary syndrome
26. Persistent high on-treatment platelet reactivity in acute coronary syndrome
27. Abnormal PFA-100 closure time is associated with increased platelet aggregation in patients presenting with chest pain
28. 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions)
29. Evaluation of platelet function in aspirin treated patients with CAD
30. Long-term hormone replacement therapy does not cause increased platelet activation
31. Evaluation of Exercise-Induced Cerebrovascular Accidents After Aortic Valve Replacement
32. Clopidogrel Use in Coronary Heart Disease and Percutaneous Coronary Intervention
33. Platelet Functional Implications of Glycoprotein Ibα Polymorphisms in African Americans
34. Heparin Therapy Leads to Platelet Activation and Prolongation of PFA-100 Closure Time
35. Genetics of Arterial Prothrombotic Risk States
36. 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions).
37. The correlation between intensive care unit attending physician continuity of care with financial and clinical outcomes
38. Editor’s Choice-The cardiovascular implications of sedatives in the cardiac intensive care unit
39. Association of Serum Sex Hormones with Hemostatic Factors in Women On and Off Hormone Therapy: The Multiethnic Study of Atherosclerosis
40. Editor’s Choice-The cardiovascular implications of sedatives in the cardiac intensive care unit
41. Genetic Regulation of Platelet Receptor Expression and Function: Application in Clinical Practice and Drug Development
42. Guided Antithrombotic Therapy: Current Status and Future Research Direction
43. Platelets and depression in cardiovascular disease: A brief review of the current literature
44. Genetic Regulation of Platelet Receptor Expression and Function
45. Abnormal PFA-100 closure time is associated with increased platelet aggregation in patients presenting with chest pain
46. Genetics of Arterial Prothrombotic Risk States
47. Activation of Platelets in Platelet-Rich Plasma by Rotablation Is Speed-Dependent and Can Be Inhibited by Abciximab (c7E3 Fab; ReoPro)
48. Guided Antithrombotic Therapy
49. LETTERS TO THE EDITOR.
50. Platelet activation and endothelial dysfunction biomarkers in acute coronary syndrome: the impact of PCSK9 inhibition.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.